Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Incomplete DJH rearrangements.

David González1, Ramón Garcia-Sanz

  • 1Department of Haemato-Oncology, Institute of Cancer Research, Surrey, UK.

Methods in Molecular Medicine
|June 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sociodemographic and clinical determinants of general practice consultation frequency among regular patients in Australia: a national study.

BJGP open·2026
Same author

High-throughput bacterial aggregation analysis in droplets.

Scientific reports·2025
Same author

Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial.

Leukemia·2025
Same author

Correlation between P53 immunohistochemical staining and TP53 molecular testing in endometrial carcinomas: a detailed assessment of discrepant cases with implications for patient management.

Histopathology·2025
Same author

Challenges in predicting outcomes for watch and wait follicular lymphoma patients: insights into clinical, pathological, and molecular factors.

Leukemia & lymphoma·2025
Same author

Technological Model to Optimize the Request for Radiological Studies.

Cureus·2025
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Detecting B-cell malignancies like multiple myeloma (MM) is improved by analyzing immunoglobulin (Ig) heavy chain gene (IgH) rearrangements. A novel approach targets incomplete DJH rearrangements, offering a more reliable method for clonality and minimal residual disease (MRD) detection in MM.

Area of Science:

  • Molecular biology
  • Immunogenetics
  • Oncology

Background:

  • Immunoglobulin (Ig) gene analysis, particularly polymerase chain reaction (PCR) amplification of Ig heavy chain gene (IgH) rearrangements, is crucial for diagnosing B-cell malignancies.
  • Current PCR methods for IgH rearrangements in multiple myeloma (MM) are often hindered by high rates of somatic hypermutation.
  • This limits their sensitivity and reliability for detecting clonality and minimal residual disease (MRD).

Purpose of the Study:

  • To introduce and validate a new PCR-based approach for detecting clonality and MRD in multiple myeloma (MM).
  • To overcome the limitations posed by somatic hypermutation in IgH gene analysis.
  • To establish a more reliable and sensitive method for MM monitoring.

Main Methods:

Related Experiment Videos

  • Development of a novel PCR strategy targeting incomplete DJH rearrangements within the Ig heavy chain gene.
  • Analysis of a cohort of multiple myeloma (MM) samples to assess the prevalence of incomplete DJH rearrangements.
  • Evaluation of the mutation status of these incomplete DJH rearrangements.

    • Main Results:

    • Approximately 60% of multiple myeloma (MM) samples harbor incomplete DJH rearrangements.
    • A significant majority (90%) of these incomplete DJH rearrangements are found to be free of somatic mutations.
    • This characteristic makes DJH rearrangements a more stable and reliable target compared to complete IgH rearrangements.

    Conclusions:

    • Incomplete DJH rearrangements represent a promising alternative target for PCR-based clonality and MRD detection in multiple myeloma (MM).
    • This approach circumvents issues related to primer mismatches caused by somatic hypermutation.
    • The use of incomplete DJH rearrangements enhances the sensitivity and reliability of molecular diagnostics for MM patients.